[Targeted therapy in EGFR-mutated lung cancer following chemoradiotherapy]

Strahlenther Onkol. 2024 Oct;200(10):921-923. doi: 10.1007/s00066-024-02284-w. Epub 2024 Aug 2.
[Article in German]
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Carcinoma, Non-Small-Cell Lung / radiotherapy
  • Carcinoma, Non-Small-Cell Lung / therapy
  • Chemoradiotherapy* / methods
  • ErbB Receptors* / antagonists & inhibitors
  • ErbB Receptors* / genetics
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / radiotherapy
  • Lung Neoplasms* / therapy
  • Molecular Targeted Therapy* / methods
  • Mutation

Substances

  • ErbB Receptors
  • EGFR protein, human
  • Antineoplastic Agents